| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005930 | axoneme | 2 | 1 |
| GO:0016020 | membrane | 2 | 3 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9B137
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.727 |
| CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.357 |
| CLV_PCSK_FUR_1 | 23 | 27 | PF00082 | 0.309 |
| CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.312 |
| CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.352 |
| CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.355 |
| CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.375 |
| DOC_MAPK_gen_1 | 23 | 33 | PF00069 | 0.525 |
| LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.525 |
| LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.538 |
| LIG_APCC_ABBA_1 | 31 | 36 | PF00400 | 0.526 |
| LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.584 |
| LIG_BRCT_BRCA1_1 | 72 | 76 | PF00533 | 0.591 |
| LIG_FHA_1 | 11 | 17 | PF00498 | 0.464 |
| LIG_FHA_1 | 147 | 153 | PF00498 | 0.679 |
| LIG_FHA_1 | 28 | 34 | PF00498 | 0.457 |
| LIG_FHA_1 | 57 | 63 | PF00498 | 0.523 |
| LIG_FHA_2 | 145 | 151 | PF00498 | 0.724 |
| LIG_FHA_2 | 99 | 105 | PF00498 | 0.649 |
| LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.565 |
| LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.495 |
| LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.555 |
| LIG_PDZ_Class_2 | 151 | 156 | PF00595 | 0.669 |
| LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.512 |
| LIG_SH2_STAT3 | 64 | 67 | PF00017 | 0.632 |
| LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.363 |
| LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.523 |
| LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.519 |
| LIG_SUMO_SIM_anti_2 | 149 | 156 | PF11976 | 0.672 |
| MOD_CK1_1 | 70 | 76 | PF00069 | 0.583 |
| MOD_CK2_1 | 98 | 104 | PF00069 | 0.670 |
| MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.411 |
| MOD_GSK3_1 | 125 | 132 | PF00069 | 0.718 |
| MOD_GSK3_1 | 142 | 149 | PF00069 | 0.754 |
| MOD_GSK3_1 | 67 | 74 | PF00069 | 0.597 |
| MOD_GSK3_1 | 78 | 85 | PF00069 | 0.615 |
| MOD_GSK3_1 | 89 | 96 | PF00069 | 0.583 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.479 |
| MOD_NEK2_1 | 75 | 80 | PF00069 | 0.664 |
| MOD_PKA_2 | 27 | 33 | PF00069 | 0.578 |
| MOD_PKA_2 | 67 | 73 | PF00069 | 0.586 |
| MOD_Plk_1 | 70 | 76 | PF00069 | 0.543 |
| MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.648 |
| MOD_Plk_4 | 71 | 77 | PF00069 | 0.561 |
| MOD_Plk_4 | 98 | 104 | PF00069 | 0.655 |
| TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.363 |
| TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.523 |
| TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.546 |
| TRG_NLS_MonoExtC_3 | 24 | 29 | PF00514 | 0.568 |
| TRG_NLS_MonoExtN_4 | 23 | 29 | PF00514 | 0.568 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5G5 | Leptomonas seymouri | 72% | 100% |
| A0A3Q8IS54 | Leishmania donovani | 90% | 100% |
| A4HIJ8 | Leishmania braziliensis | 76% | 100% |
| A4I5U2 | Leishmania infantum | 90% | 100% |
| Q4Q729 | Leishmania major | 89% | 100% |
| V5DP06 | Trypanosoma cruzi | 50% | 99% |